Home/Australian Tariffs/From Austria/Pharmaceutical products

Importing Pharmaceutical products from Austria into Australia (2026)

No FTA exists between Australia and Austria so full MFN duty rates apply to all Chapter 30 pharmaceutical imports; the single most critical compliance obligation is confirming each product holds a current ARTG listing before the shipment departs Austria, as ABF will hold unconfirmed goods at the border.

No FTA — MFN rates applyHS Chapter 30

Compliance requirements

  • Verify ARTG registration for every product line prior to booking the shipment from Austria.
  • Ensure your TGA Import Licence specifically covers the Austrian pharmaceutical goods being imported.
  • For any narcotic or psychotropic lines, lodge ODC permit applications at least 15 business days before shipment.
  • All therapeutic goods for human use must be listed or registered on the Australian Register of Therapeutic Goods (ARTG) before importation — ABF will hold shipments if the ARTG entry cannot be confirmed at the border
  • The importer must hold a current TGA Manufacturing or Import Licence (issued under the Therapeutic Goods Act 1989) — this licence must match the specific goods being imported, and spot audits do occur
  • Narcotic, psychotropic, and certain precursor substances require a permit from the Office of Drug Control (ODC) under the Narcotic Drugs Act before each shipment; permits are shipment-specific so plan lead times of 10–15 business days
  • Biological medicines, vaccines, and any product of animal origin require DAFF biosecurity assessment and may need a Biosecurity Import Permit — cold-chain integrity documentation is also scrutinised at the border for temperature-sensitive biologics
  • Goods exempt from ARTG registration (e.g. certain compounded medicines or personal use exemptions) still require a formal TGA exemption reference to be cited on the import declaration to avoid ABF detention
  • No FTA exists between Australia and Austria so MFN general tariff rates apply to all imports; a commercial invoice with accurate country of origin declaration is required but no preferential certificate of origin is applicable
  • Electrical and electronic goods must meet ACMA regulatory arrangements including RCM marking compliance under the Radiocommunications Act and Telecommunications Act before entry into the Australian market
  • Timber, wooden products, and any goods containing plant material are subject to DAFF biosecurity inspection and may require a phytosanitary certificate or heat treatment declaration under Australias Biosecurity Act 2015
  • Pharmaceutical and medical device imports from Austria must be listed or registered on the Australian Register of Therapeutic Goods (ARTG) administered by the TGA prior to importation, and relevant permits may be required for controlled substances

Key documents required

  • commercial invoice citing ARTG registration or listing number for each product line
  • TGA Import Licence or Manufacturing Licence copy (held by the importer of record)
  • Office of Drug Control (ODC) import permit for controlled substances (Schedule 8 or precursor chemicals)
  • Certificate of Analysis (CoA) and Manufacturer's Certificate of GMP Compliance or equivalent TGA-accepted GMP clearance
  • DAFF Biosecurity Import Permit and cold-chain temperature records for biologics, vaccines, or animal-derived products

Import tip

Lodge your ODC controlled substance import permit application at least three weeks before the vessel or aircraft departs origin — ODC permits cannot be expedited after shipment, and a single missing permit number on the import declaration will result in ABF referral and potential destruction of the consignment.

Calculate the total landed cost for Chapter 30 goods from Austria — duty, GST, IPC, and biosecurity included.

Other product categories imported from Austria